|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
3.85(B) |
Last
Volume: |
282,124 |
Avg
Vol: |
696,159 |
52
Week Range: |
$36.45 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
5 |
5 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gray David C |
Chief Strategy & New Business |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
94,306 |
|
- |
|
Sriram Vandana |
VP, Finance & Corp. Controller |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(81) |
3,468 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(680) |
6,602 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,236 |
7,282 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,091) |
110,883 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,403 |
120,974 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,838) |
28,456 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,077 |
34,294 |
|
- |
|
Joseph Jason |
SVP, General Counsel, Secy. |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,535) |
96,002 |
|
- |
|
Joseph Jason |
SVP, General Counsel, Secy. |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,687 |
100,537 |
|
- |
|
Crowley Kimberly |
SVP, Chief HR Officer |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(574) |
4,703 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,293) |
401,641 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
48,580 |
427,934 |
|
- |
|
Mcmanus Matthew |
EVP & Chief Operating Officer |
|
2022-08-19 |
4 |
B |
$58.15 |
$501,544 |
D/D |
8,625 |
29,467 |
2.74 |
1% |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2022-08-19 |
4 |
B |
$57.62 |
$250,647 |
D/D |
4,350 |
100,571 |
2.74 |
1% |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2022-07-29 |
4 |
A |
$57.49 |
$5,634 |
D/D |
98 |
96,221 |
|
- |
|
De Jesus Linda |
Chief Commercial Officer, LS |
|
2022-07-29 |
4 |
A |
$57.49 |
$2,472 |
D/D |
43 |
2,764 |
|
- |
|
Sriram Vandana |
VP, Finance & Corp. Controller |
|
2022-07-29 |
4 |
A |
$57.49 |
$16,787 |
D/D |
292 |
3,549 |
|
- |
|
Crowley Kimberly |
SVP, Chief HR Officer |
|
2022-07-29 |
4 |
A |
$57.49 |
$8,279 |
D/D |
144 |
5,277 |
|
- |
|
Crowley Kimberly |
SVP, Chief HR Officer |
|
2022-04-12 |
4 |
S |
$78.02 |
$10,299 |
D/D |
(132) |
5,133 |
|
28% |
|
Sriram Vandana |
VP, Finance & Corp. Controller |
|
2022-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,257 |
|
-15% |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2022-01-31 |
4 |
A |
$69.29 |
$13,096 |
D/D |
189 |
96,123 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2022-01-31 |
4 |
A |
$69.29 |
$19,748 |
D/D |
285 |
23,217 |
|
- |
|
Crowley Kimberly |
SVP, Chief HR Officer |
|
2022-01-31 |
4 |
A |
$69.29 |
$7,622 |
D/D |
110 |
5,265 |
|
- |
|
Mcmanus Matthew |
EVP & Chief Operating OfficerO |
|
2022-01-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,842 |
|
-5% |
|
1054 Records found
|
|
Page 4 of 43 |
|
|